Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Healthcare Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

TSX:OPS - Post Discussion

Opsens Inc > Necessary to have funds to develop...
View:
Post by bossu on Dec 22, 2022 8:51pm

Necessary to have funds to develop...

OPS is taking ''preventive''step to expand and demonstrate their outstanding product going forward !
Actually 300 persons  or so are working on the production and development to increase  the  top line revenue !
From the 2022 $ 35 M revenue they need to show more than 15% increase in the H2 2023 or deliver a $ 40 M revenue !
If not, I bail out Mr Lafamme
Comment by eiementai on Dec 23, 2022 1:15am
This post has been removed in accordance with Community Policy
Comment by bossu on Dec 23, 2022 2:10pm
FromSarugaser “We continue to have strong long-term conviction that SavvyWire’s unique 3-in-1 TAVR capability represents compelling commercial potential that could drive OPS’ top-line revenue to $100-million by 2026, so we maintain our rating at Outperform.” Possible number and $ 40M in 2023 i the guidance OPS should provide                     & ...more  
Opsens Inc